Debrecen, Hungary

Katalin Kovacs-Hadadi

This inventor holds 1 USPTO granted patent. Top assignee: Biogal Gyogyszergyar Rt.. Active years: 1994.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Katalin Kovacs-Hadadi. Retrieved from https://idiyas.com/inventor/katalin-kovacs-hadadi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1994

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Katalin Kovacs-Hadadi: Innovator in Pharmaceutical Chemistry

Introduction

Katalin Kovacs-Hadadi is a prominent inventor based in Debrecen, Hungary. She has made significant contributions to the field of pharmaceutical chemistry, particularly through her innovative work on 1-triacontanol derivatives. Her research has the potential to impact various applications in medicine and agriculture.

Latest Patents

Kovacs-Hadadi holds a patent for 1-triacontanol derivatives, showcasing her expertise in developing new chemical compounds. This patent represents her commitment to advancing scientific knowledge and practical applications in her field. She has 1 patent to her name, reflecting her innovative contributions.

Career Highlights

Katalin is currently employed at Biogal Gyogyszergyar Rt., a company known for its focus on pharmaceutical development. Her role at Biogal allows her to apply her research findings in a practical setting, contributing to the development of new therapeutic solutions.

Collaborations

Throughout her career, Katalin has collaborated with notable colleagues, including Antal Kovacs and Andras Liptak. These partnerships have enriched her research and expanded the impact of her work in the scientific community.

Conclusion

Katalin Kovacs-Hadadi is a dedicated inventor whose work in pharmaceutical chemistry continues to inspire innovation. Her contributions, particularly in the area of 1-triacontanol derivatives, highlight her role as a key figure in advancing scientific research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…